Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Head & Neck 1Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 1Stomach Neoplasms 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Neoplasm Metastasis 1Head and Neck Neoplasms 1Gastrointestinal Stromal Tumors 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Biliary Tract Neoplasms 1

Interventions

Cyclophosphamide 5Fluorouracil 4pembrolizumab 3fludarabine 3Gemcitabine 3Docetaxel 3Cisplatin 3belinostat 2Quality of Life 2Psychiatric Rehabilitation 2Oxaliplatin 2Observation 2Leucovorin 2Irinotecan 2Filgrastim 2Erlotinib Hydrochloride 2Drug Therapy 2Cetuximab 2Carboplatin 2Blood Specimen Collection 2Bevacizumab 2130-nm albumin-bound paclitaxel 2umbralisib 1trifluridine tipiracil drug combination 1trastuzumab deruxtecan 1toripalimab 1seribantumab 1rucaparib 1resiquimod 1poly ICLC 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophageal Neoplasms × TAS-116 × Sarcoma × Clear all
NCT04999761 2024-09-25

AB122 Platform Study

Taiho Pharmaceutical Co., Ltd.

Phase 1 Recruiting
917 enrolled
GastrointestinalHead & NeckSarcomaThoracic

Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Stomach Neoplasms, Colorectal Neoplasms, Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon âš¡